Publications by authors named "James Novotny"

Claim this Profile
A
Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types.
Gabriel S Krigsfeld, Emily A Prince, James Pratt, Vladislav Chizhevsky, Josette William Ragheb, James Novotny

J Clin Pathol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma.
Therese Phillips, Molly M Millett, Xiaoling Zhang, Malinka Jansson, Rachel Cleveland, James Novotny

Appl Immunohistochem Mol Morphol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1.
John Cogswell, H David Inzunza, Qiuyan Wu, John N Feder, Gabe Mintier, James Novotny

Mol Diagn Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
Fred R Hirsch, Abigail McElhinny, Dave Stanforth, James Ranger-Moore, Malinka Jansson, James Novotny

J Thorac Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
Therese Phillips, Pauline Simmons, Hector D Inzunza, John Cogswell, James Novotny

Appl Immunohistochem Mol Morphol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis